请回答1997一线见闻｜废海水生“金” 价值“三连跳”_我的网站
A | 日前，唐山蓝仓海洋科技有限责任公司员工在查看设备运行情况。
B |  China has granted marketing approval of its first drug for the prevention of acute mountain sickness, filling the long-standing gap in the domestic market where no such medications had been available, Science and Technology Daily reported on Tuesday. The National Medical Products Administration (NMPA) has approved the marketing of acetazolamide sustained-release capsules, the report said. As the first specialized drug in China indicated for preventing of acute mountain sickness, its approval marks the end of the country's lack of dedicated preventive treatment for altitude illness. By inhibiting the activity of carbonic anhydrase, acetazolamide promotes the renal excretion of bicarbonate, corrects respiratory alkalosis caused by hypoxia at high altitudes, thereby regulating acid-base balance, optimizing respiratory status, elevating blood oxygen levels, and reducing the risk of onset at the source. In contrast to health products that only provide auxiliary regulatory effects, this medication has been validated through stringent clinical trials and stands as a specialized drug approved by the NMPA with a clear indication for prevention, said the report. Led by principal investigator is Luobu Gesang, a deputy dean of the People's Hospital of Xizang Autonomous Region, the clinical trial was designed by his team and has yielded critical evidence to inform prevention strategies for altitude sickness that are specifically adapted to Chinese and Asian populations. "Previously, although acetazolamide had already been used internationally for the prevention of acute mountain sickness, China had long lacked an NMPA-approved acetazolamide formulation supported by rigorous clinical trials. Furthermore, the existing international formulations were short-acting tablets requiring multiple daily doses, and no drugs with the relevant indication were available on the domestic market for an extended period," said Luobu Gesang. The sustained-release capsule approved this time not only fills this critical gap but also optimizes the dosage form, providing more reliable and convenient medication protection for the physical health and life safety of people entering high-altitude areas, he added. Clinical trials showed that, compared with the placebo group, the incidence of acute mountain sickness in the medication group was significantly reduced, with the incidence of moderate-to-severe acute mountain sickness decreasing by 14.6 percent, according to the report. Related research has been published in the international flagship journal of high-altitude medicine, High Altitude Medicine & Biology. Global Times 。日报记者 赵杰摄日报讯（记者王育民）“设备运行正常。”8月10日一早，唐山蓝仓海洋科技有限责任公司经理曹文强便来到生产车间，对设备运行情况进行检查。曹文强一心牵挂的，是不久前正式投产的年产4000吨溴素项目一期。“这是我们生产的溴素，纯度已经达到了一级品标准。”他指着一瓶看似碘伏的液体说，一吨溴素售价约3.2万元，而它的源头就是以往被视作废弃物的海水。蓝仓公司所在的唐山海港经济开发区，因海而生，海水资源十分丰富。
C | “这个项目的正式投产，打通了海洋资源综合利用产业链。”该经开区发改局相关负责人说，从废海水里提“金”，价值实现“三连跳”。
D | 蓝仓公司东侧，仅一墙之隔，是唐山申港海水淡化有限公司。两家公司管道相连，是产业链的上下游。“我们的废水是蓝仓公司的宝贝。
E | ”申港公司副总经理马海龙说，他们“吃”进电厂发电冷却水，“吐”出淡化海水和提溴素用浓海水，成了产业链中的枢纽。通过产业链示意图记者看到，申港公司的上游是大唐王滩电厂。海港经开区及周边区域聚集着多家钢铁、焦化企业，工业用水量巨大。
F | 然而，市政供水量有限，向大海“要水”成了破局的关键。据了解，大唐王滩电厂采用海水直流冷却工艺，与同等规模的火电循环冷却模式相比，机组满负荷运行每日可节约淡水上万吨。
G | 而电厂冷却后产生的温海水，是申港公司海水淡化不可多得的好原料。马海龙解释，简单来说，海水淡化就是将海水中的盐和水分离开来，对水温要求较高。
H | 如果水温低于零摄氏度，分离后形成的淡水便会上冻，影响下一步生产。从电厂到海水淡化厂，原本废弃的温海水实现价值“第一跳”。
I | 申港公司厂区里管线遍布，大多数管道通向附近的工业企业。“每2.5吨废弃温海水进去，可产出1吨淡水，而且经过淡化的海水矿物质和杂质少。”马海龙介绍，下游企业用了它，既省了二次过滤的钱，又能保护核心设备。如今，申港公司海水淡化一期项目建成投产，二期项目已投入试运营，日产能达10万吨。在这里，海水价值有了“第二跳”。一头将淡化海水送到工业企业，一头将废弃浓海水输进蓝仓公司。目前，蓝仓公司每日可利用申港公司7.5万吨废弃浓海水，提取6吨溴素，日产值超19万元。这样，从废弃浓海水中提取溴素，价值又实现跨越式“第三跳”。
J | 作为基础化工原料，溴素广泛应用于阻燃剂、医药中间体以及农用化学品等领域。“当前，我国每年需大量进口溴素，以满足工业发展的需要。”曹文强说，他们的产品还未正式销售，已有20多家经销商主动联系。眼下，蓝仓公司的二期项目正在加紧推动。建成投产后，海港经开区的海洋资源综合利用产业链含金量将越来越足。 Current article:http://5snbknq.sunaichitikouchua.bond/aod6bd/20260826/9847.html Published on:13:42:00 |
